Large‐scale proteomic analyses of AD brain tissue and CSF (Bai et al, 2020; Johnson et al, 2020) continue to reveal more AD‐linked proteins, such as increased CD44 in the CSF of AD patients (Johnson et al, 2020). Here, CD44 is linked to Alzheimer disease.